Anti-Biofilm Properties of Laser-Synthesized, Ultrapure Silver-Gold-Alloy Nanoparticles against Staphylococcus aureus

doi:10.21203/rs.3.rs-3337662/v1

Download PDF

Article

Anti-Biofilm Properties of Laser-Synthesized, Ultrapure Silver-Gold-Alloy Nanoparticles against Staphylococcus aureus

https://doi.org/10.21203/rs.3.rs-3337662/v1

This work is licensed under a CC BY 4.0 License

Journal Publication

published 10 Feb, 2024

Read the published version in Scientific Reports →

You are reading this latest preprint version

Staphylococcus aureus biofilm-associated infections are a common complication in modern medicine. Due to inherent resilience of biofilms to antibiotics and the rising number of antibiotic-resistant bacterial strains, new treatment options are required. For this purpose, ultrapure, spherical silver-gold-alloy nanoparticles with homogenous elemental distribution were synthesized by laser ablation in liquids and analyzed for their antibacterial activity on different stages of S. aureus biofilm formation as well as for different viability parameters. First, the effect of nanoparticles against planktonic bacteria was tested with metabolic activity measurements. Next, nanoparticles were incubated with differently matured S. aureus biofilms, which were then analyzed by metabolic activity measurements and three dimensional live/dead fluorescent staining to determine biofilm volume and membrane integrity. It could be shown that AgAu NPs exhibit antibacterial properties against planktonic bacteria but also against early-stage and even mature biofilms, with a complete diffusion through the biofilm matrix. Furthermore, AgAu NPs primarily targeted metabolic activity, to a smaller extend membrane integrity, but not the biofilm volume. Additional molecular analyses using qRT-PCR confirmed the influence on different metabolic pathways, like glycolysis, stress response and biofilm formation. As this shows clear similarities to the mechanism of pure silver ions, the results strengthen silver ions to be the major antibacterial agent of the synthesized nanoparticles. In summary, the results of this study provide initial evidence of promising anti-biofilm characteristics of silver-gold-alloy nanoparticles and support the importance of further translation-oriented analyses in the future.

Biological sciences/Microbiology

Health sciences/Medical research

Physical sciences/Nanoscience and technology

Bacterial implant-associated infections frequently cause severe complications in modern medicine^1–4. The treatment of these infections remains difficult although a plethora of antibiotics is available, since infection sites are difficult to reach for systemically administered antibiotics due to missing vascularization of implants^5–7, the rise of multidrug-resistant bacterial strains^8,9, and the formation of bacterial biofilms^10–12. Biofilms are single- or multi-species microbial communities encapsulated in a matrix of self-produced extracellular polymeric substances and inherently resistant to antimicrobial substances^11,13,14. One of the most relevant bacterial species in implant-associated infections is the gram-positive Staphylococcus aureus. It has already been detected on orthopedic, cardiovascular, and dental implants¹⁵. It is also one of the most relevant species with regard to antibiotic resistance due to the SCCmec gene complex that encodes resistance to most β-lactam antibiotics¹⁶. One example is methicillin-resistant S. aureus (MRSA) with an estimated prevalence of almost 150,000 cases and over 7,000 deaths per year in the countries of the European Union and the European Economic Area¹⁷. In southern Europe, 24-43 % of isolated S. aureus strains from invasive infections in 2021 were identified as MRSA¹⁸.

To overcome resistance against antibiotics, alternative treatments are within the focus of current research. For this purpose, several approaches, like modification of antimicrobials to circumvent resistance mechanisms, compounds that inhibit mechanisms of resistance, new antimicrobial target proteins, inhibiting virulence factors, nanoparticles, antimicrobial peptides, phages, or antisense oligonucleotides are pursued¹⁹. Amongst them, silver has already frequently been studied for medical applications²⁰. Silver ions prevent growth of bacteria by inhibiting several enzymes relevant for glycolysis, the pentose phosphate pathway, the electron transport chain, and the oxidative stress defense system²¹. Due to their large effective surface area and consequent high ion release, nanoparticles are an effective way to apply silver and have already been used for medical applications, e.g., wound and burn treatment²². However, silver ions have also shown toxicity towards eukaryotic cells²³. Once inside the cell, silver ions can induce production of reactive oxygen species (ROS), which lead to protein denaturation, DNA damage, and finally cell death²⁴. Consequently, bacteria and human cells often react to similar silver concentrations, which narrows the therapeutic window – defined as a concentration range that is antibacterial but not cytotoxic.

To reduce cytotoxicity, silver-gold-alloy nanoparticles (AgAu NPs) have been introduced^25–27. It has already been shown that alloying silver nanoparticles with gold reduces toxicity towards human cell cultures disproportionally to the silver-to-gold ratio²⁸. This is hypothesized to be due to a reduced silver ion release caused by the gold²⁷. Gold can also serve as an anchor to selectively couple target-specific entities to nanoparticles, which would be interesting for further modifications²⁹. When AgAu NPs are synthesized by laser ablation in liquid (LAL), ultrapure, spherical nanoparticles with homogenous elemental distribution defined by the target, reproducible particle sizes, and free of additional surfactants can be produced^30–32. Due to the complete miscibility of silver and gold, all silver-to-gold ratios can be achieved³⁰.

The antibacterial effect against S. aureus of AgAu NPs synthesized by LAL has already been tested in an agar diffusion assay²⁸. The minimum inhibitory concentration was 25 µg/mL for AgAu NPs consisting of 80 % silver atoms and 20 % gold atoms and stabilized by BSA. However, in this assay, planktonic bacteria are streaked out on agar plates containing AgAu NPs and grow in colonies²⁸. Therefore, the physiological biofilm morphology that is mostly the cause for implant-associated infections and considerably more tolerant against treatment is not considered^10,33. To the authors’ knowledge, there is no record in the literature how AgAu NPs synthesized by LAL would affect S. aureus biofilms.

This study aims to analyze the effect of surfactant free AgAu NPs synthesized by LAL on different stages of S. aureus biofilm formation and on different parameters for bacterial viability. For this purpose, they were first tested against planktonic bacteria with metabolic activity measurements. They were then incubated with differently matured S. aureus biofilms. The biofilms were analyzed by metabolic activity measurements and three dimensional live/dead fluorescent staining to determine biofilm volume and membrane integrity. To further investigate the antibacterial mechanism of AgAu NPs, gene expression of S. aureus after treatment with AgAu NPs was analyzed and compared to the effect of pure silver ions.

Generation of AgAu NPs with monodisperse size distribution and molar gold fraction of 0.2

To verify whether the desired elemental composition was achieved and to analyze the size distribution of nanoparticles, UV-Vis spectroscopy, X-ray-fluorescence (XRF) spectroscopy, and transmission electron microscopy (TEM) were used. UV-Vis spectroscopy (Figure 1A) revealed a single absorbance peak at roughly 415 nm. A gold molar fraction of 0.2 determined by XRF can be observed in Figure 1B. Number-weighted particle size distributions derived from TEM analysis showed a mean nanoparticle diameter of 8 ± 3.5 nm (Figure 1C).

Reduced metabolic activity of planktonic S. aureus upon treatment with AgAu NPs

First, the effect of AgAu NPs on planktonic S. aureus was analyzed. Viability was measured using a resazurin assay after incubation with different surface concentrations of AgAu NPs for 3 h in either 0.2 mM NaCl or binding buffer. The results are shown in Figure 2. All data were normalized to the untreated group (0 cm²/mL) in the respective medium. Metabolic activity of planktonic bacteria decreased with increasing concentration of AgAu NPs to a comparable degree in both media. A surface concentration of 1.25 cm²/mL was sufficient to decrease relative metabolic activity statistically significantly by about 81 ± 4 % in 0.2 mM NaCl and 93 ± 2 % in binding buffer. This difference between media was small but also statistically significant.

Different effects of AgAu NPs on S. aureus biofilm viability, volume and membrane integrity

Mature biofilms are known to be much more resistant to antimicrobial substances than planktonic bacteria^11,33. To take this into account, S. aureus was incubated in tryptone soya broth supplemented with 10 % yeast extract (TSBy) and 50 mM glucose at 37 °C for either 5 h or 24 h to obtain biofilms of different maturity. These biofilms were subsequently treated with AgAu NPs for 18 h in either 0.2 mM NaCl or binding buffer. Like planktonic bacteria, biofilms were analyzed with a resazurin assay to determine their metabolic activity and data were normalized to the control (0 cm²/mL). To additionally analyze volume and membrane integrity, biofilms were fluorescently stained with live/dead fluorochromes and images were taken using confocal laser scanning microscopy (CLSM).

The results for the 5 h old biofilms are shown in Figure 3. Metabolic activity (Figure 3A) was reduced with increasing AgAu NP concentration in both media with a statistically significant decrease by 70 ± 5 % in NaCl and 93 ± 2 % in binding buffer when using 25 cm²/mL. For NaCl, the bacterial viability was already statistically significantly reduced by 22 ± 8 % at 10 cm²/mL. The difference between 10 cm²/mL and 25 cm²/mL in NaCl was also statistically significant. In case of binding buffer, no difference could be detected for the lower concentration. Based on these results, a concentration of 25 cm²/mL was chosen for microscopic biofilm evaluation. As shown in Figure 3B and D, biofilm volume did not change upon treatment with AgAu NPs. On average it reached 7.8×10⁴ ± 2.7×10⁴ µm³ and 3.5×10⁴ ± 1.6×10⁴ µm³ in NaCl and binding buffer, respectively. In contrast, differences could be observed for biofilm membrane integrity (Figure 3C, D). For binding buffer, untreated biofilms had 11 ± 9 % cells with damaged membranes and their amount statistically significantly increased when incubated with AgAu NPs to 21 ± 14 %. Untreated biofilms in NaCl showed 63 ± 13 % cells with damaged membranes. The amount statistically significantly decreased upon treatment with AgAu NPs to 51 ± 9 %. For both, biofilm volume and membrane integrity, the differences between media were statistically significant as well.

In Figure 4, the results for the 24 h old biofilms are depicted. Metabolic activity (Figure 4A) was statistically significantly reduced by 31 ± 14 % in NaCl and by 26 ± 5 % in binding buffer when using 25 cm²/mL of AgAu NPs. In NaCl, the reduction was statistically significant with 37 ± 11 % at 10 cm²/ml. There was no statistically significant difference between the two treatment concentrations in NaCl. In binding buffer, treatment with the lower concentration did not result in a statistically significant difference in metabolic activity to the control. Again, a concentration of 25 cm²/mL was chosen for microscopic biofilm evaluation. Biofilm volume (Figure 4B) was unaffected by AgAu NPs and was on average 1.5×10⁵ ± 5.6×10⁴ µm³ and 7.2×10⁴ ± 3.8×10⁴ µm³ in NaCl and binding buffer, respectively. Membrane integrity (Figure 4C, D) however, was statistically significantly reduced in both media. Untreated biofilms consisted of 8 ± 3 % and 5 ± 2 % cells with damaged membranes in NaCl and binding buffer, respectively, increasing to 15 ± 5 % and 13 ± 7 % in the presence of the AgAu NPs. The differences between media were statistically significant for biofilm volume and the untreated group of membrane integrity.

Complete diffusion of AgAu NPs through S. aureus biofilms

One of the major defense mechanisms of biofilms is the EPS matrix serving as a diffusion barrier for antimicrobial substances³³. To analyze whether AgAu NPs diffuse through 24 h old S. aureus biofilms, single planes were extracted from the 3D images created by CLSM every 4 µm starting from the bottom of the biofilms. In these planes, membrane integrity was determined. The results are shown in Figure 5. It can be observed that in all biofilms the highest percentage of damaged cells was in the bottom layer. For untreated biofilms, the percentage of bacteria with damaged membranes was 6 ± 2 % and 3 ± 7 % in NaCl and binding buffer, respectively. For treated biofilms, the percentage of damaged cells is increased evenly in the whole biofilm and the bottom layer still contains the highest amount with 12 ± 7 % in NaCl and 5 ± 4 % in binding buffer.

AgAu NPs target expression of S. aureus metabolic genes

To further analyze the antibacterial mechanism of AgAu NPs, expression of known silver target as well as biofilm relevant genes was quantified in planktonic S. aureus after treatment with 1 mg/L AgNO₃ or 1.25 cm²/mL AgAu NPs using qRT-PCR and compared to a control (0 mg/L or 0 cm²/mL, respectively). The data was analyzed using the 2^-^ΔΔ^C^T-method³⁴ with rrsA as housekeeping gene. The results are shown in Figure 6 as y-fold expression compared to the housekeeping gene and the control.

In Figure 6A, the influence of silver ions dissolved from AgNO₃ can be observed. Expression of pfkA and ahpD is statistically significantly increased to 4.4 ± 2.9-fold and 24.6 ± 16.5-fold, respectively. Expression of icaR is slightly reduced to 0.6 ± 0.4, however, this reduction is not statistically significant. The influence of AgAu NPs is depicted in Figure 6B. Here, the expression of pfkA is also increased. With an increase to 1.6 ± 0.2-fold, it is less pronounced than for AgNO₃ and with a p-value of 0.0668 not defined as statistically significant. However, it is close to the threshold of 0.05. In contrast to AgNO₃, the expression of ahpD is statistically significantly reduced to 0.04 ± 0.02-fold under the influence of AgAu NPs. The expression of icaR is statistically significantly reduced to 0.2 ± 0.06-fold like for AgNO₃.

AgAu NPs are a promising approach as alternative antibacterial substance due to the combination of antibacterial and biocompatible elements. Synthesis by LAL allows for ultrapure, spherical AgAu NPs with homogenous elemental distribution and reproducible particle sizes. However, so far, the antibacterial effect of these particles has not been tested on physiologically relevant biofilms, which are known for their inherent resistance to antimicrobial agents. In this study, the effect on S. aureus biofilms, one of the major pathogens in implant-associated infections, was investigated. Albeit biofilms are considerably more tolerant than planktonic bacteria, an antibacterial effect throughout the entire thickness of the biofilms was observed. The AgAu NPs showed their strongest effect on metabolic activity, which could be additionally verified by targets on the molecular level.

Initial characterization of the AgAu NPs generated by LAL in this study showed a clear absorbance peak in UV-Vis-extinction spectroscopy associated to the localized surface plasmon resonance (SPR) of a colloid consisting of 80 mol% silver and 20 mol% gold. As only one peak is observable, large deviations in composition as well as formation of larger fractions of pure Ag and Au nanoparticles could be excluded. The SPR maximum at ~415 nm is in good accordance with previous findings and can be associated with a gold molar fraction of ~0.2, which is close to the nominal composition of the target^31,32,35. The results are further confirmed by XRF analysis, where a gold molar fraction of 0.2 was determined for the bulk colloid which is in line with previous characterization approaches based on XRD³² as well as single particle TEM-EDX³¹. Number-weighted particle size distributions derived from TEM analysis indicate a monodisperse and monomodal particle size distribution with a mean diameter of 8 ± 3.5 nm, with errors derived from the variance (width) of the log-normal distribution curves. Therefore, it can be concluded that the nanoparticle colloids used in this study had a monodisperse particle size distribution and a gold molar fraction of 0.2, closely matching that of the target used during ablation.

When these particles were used for antibacterial testing in this study, all assays were done in 0.2 mM NaCl and in binding buffer. NaCl was the solution in which the nanoparticles were synthesized and in which they were most stable, based on the influence of ionic strength on stability of ligand-free particles²⁷. However, 0.2 mM NaCl can be considered a hypoosmolaric system for bacteria. In contrast, binding buffer is much more comparable to physiological buffers like phosphate buffered saline based on its ion concentration. Furthermore, it enables functionality of possible further target specific entities, like species-specific aptamers^30,36. It also has to be mentioned that nanoparticle concentrations were measured in surface area per volume instead of mass per volume in this study. This was due to the fact that silver nanoparticles do not dissolve in aqueous liquids. Instead, a small amount of silver ions is released from the particle surface and is responsible for biological effects. Hence, particle mass, which is not located at the surface, is not relevant for functionality of these particles, only the active surface contributes silver ions. This is the reason for different effects between nanoparticles and bulk materials and results in surface area being a more meaningful parameter for nanoparticle functionality than total mass^30,37. Furthermore, surface weighted concentrations are more meaningful than mass weighted ones when comparing different nanoparticle types that may vary in particle size and density.

To initially test antibacterial activity, planktonic S. aureus was incubated with different concentrations of AgAu NPs for 3 h and metabolic activity was determined using a resazurin assay. Resazurin (7-hydroxy-10-oxidophenoxazin-10-ium-3-one) is a membrane permeable, blue, non-fluorescent dye. Once inside the cell, it can be irreversibly reduced by the reducing equivalents FMNH₂, FADH₂, NADH, or NADPH to the pink, fluorescent resorufin³⁸. By measuring the increasing fluorescent signal, metabolic activity can be quantified. This assay is a well-established method to analyze antibacterial effects³⁹.

The results showed that an AgAu NP concentration of 1.25 cm²/mL was sufficient to reduce metabolic activity by 81 % to 93 %, depending on the medium, which could be considered a strong antibacterial effect. Silver ions are known to affect, amongst others, the enzymes PdhB, which is responsible for a reduction of NAD⁺ to NADH during glycolysis, and 6PGDH, which is part of the reduction of NADP⁺ to NADPH/H⁺ in the pentose phosphate pathway²¹. Consequently, less of these molecules are left to reduce resazurin after treatment with AgAu NPs. Other enzymes relevant for these intracellular mechanisms are affected by silver ions as well, for example PfkA in glycolysis and Pgl in the pentose phosphate pathway²¹. This further decreases the amount of available NADH and NADPH and finally disrupts the cellular metabolism. The slight difference between binding buffer and 0.2 mM NaCl might be explained by the absolute fluorescence readout values of the resazurin assay (not shown). In 0.2 mM NaCl, the values were roughly 33 % lower than in binding buffer, which means metabolic activity is generally reduced in this medium. This could most probably be attributed to the fact that 0.2 mM is a very low concentration of NaCl and the pH of the solution was between 4.5 and 5. These conditions deviate to a high extent from physiological growth conditions of bacteria. Consequently, this could mask or impair the effect of AgAu NPs by influencing the uptake of silver ions or how much metabolic activity could be further reduced by an antibacterial effect. It is also conceivable that the dissolution equilibrium of the AgAu NPs was affected by pH and particularly the chloride concentration. A strong antibacterial activity on planktonic bacteria is typical for other types of nanoparticles containing silver as well. Salunke et al. found that their biologically synthesized Ag NPs, Au NPs, and AgAu NPs exhibited a minimum inhibitory concentration (MIC) of 8 µg/mL against S. aureus, each⁴⁰. Gurunathan et al. also synthesized their Ag NPs biologically and reported an MIC of 0.75 µg/mL against S. aureus (colony forming units (CFU) reduced by roughly 99 %)⁴¹. Bhatia and Banerjee reported an MIC of 10 µg/mL against S. aureus for their chemically synthesized AgAu NPs⁴². For the AgAu NPs used in this study, with an average size of 8 nm and a molar silver-to-gold ratio of 4:1, the effective concentration of 1.25 cm²/mL AgAu NPs corresponds to roughly 1.75 µg/mL of silver. This is in the same magnitude as the MICs in literature, with a relatively strong antibacterial effect. The slight differences in MICs can most probably be attributed to the nanoparticle size, as it was on average 35 nm, 5 nm, and 40 nm in their studies, respectively^40–42. Since silver from nanoparticles does not dissolve completely but rather nanoparticles release only a small amount of their silver as ions, size and, thus, active surface area affect how many nanoparticles are required for the same effect.

Compared to planktonic bacteria, biofilms are much more resistant to antibacterial action ^11,13,14. Therefore, antibacterial results cannot be simply transferred but need to be tested individually. For this purpose, AgAu NPs were first tested on early-stage biofilms, which were grown for 5 h only. Preliminary experiments had shown that, for a similarly distinct effect compared to planktonic bacteria, increasing nanoparticle concentration alone had not been sufficient but also longer treatment times were needed. Therefore, 5 h old biofilms were incubated with 10 cm²/mL or 25 cm²/mL AgAu NPs for 18 h and metabolic activity was determined using the resazurin assay. Additionally, biofilms incubated with or without 25 cm²/mL AgAu NPs were stained with two fluorescent dyes. Red prodidium iodide can only stain cells with damaged membranes whereas green SYTO9 is able to enter and stain cells with intact membranes. CLSM was then used to acquire 3D images which could be analyzed for biofilm volume and distribution of membrane integrity.

The results showed an effect of AgAu NPs on metabolic activity and membrane integrity of S. aureus early-stage biofilms. Although a 20-times higher nanoparticle concentration was required for a similar effect than on planktonic bacteria, metabolic activity of early-stage biofilms was drastically reduced by AgAu NPs. A considerably higher resilience towards antimicrobial substances is typical for biofilms, while the here reported decrease in susceptibility is at the low end of the 10-1,000-fold decrease found in literature^11,33. This resilience is most likely explained by reduced diffusion of the antibacterial substance through the biofilm matrix^43,44 and a large amount of bacteria being in the stationary phase and thus being affected less by anti-metabolic action^45,46. Another aspect, why a higher concentration of nanoparticles is needed might be the larger number of bacteria being present. The effect of AgAu NPs on membrane integrity was considerably weaker than on metabolic activity. This difference between different viability parameters can most probably be explained by silver’s mechanism of action. As described above, silver damages various metabolic pathways in S. aureus, strongly affecting metabolic activity²¹. However, disruption of membrane to the point of the membrane being permeable for propidium iodide seems to be a minor silver target compared to metabolic pathways. Even though other studies also reported disruption of membranes of S. aureus and E. coli by silver, they did not compare it to metabolic activity^47–49. Therefore, future studies should address this observation in more detail by also analyzing whether reduction of membrane integrity is due to direct damage from AgAu NPs or a second-level result of cell death from damage to metabolic pathways. In contrast to metabolic activity and membrane integrity, biofilm volume was not affected by AgAu NP treatment. Again, this is in line with silver’s mechanism of action. As the biofilm has already been matured before treatment, silver would have needed to exert eradicative properties to reduce biofilm volume. However, these properties have not been described for silver.

For all viability parameters of early-stage biofilms treated with AgAu NPs, there are also significant differences between the media used. In binding buffer, biofilms present with less than half of the volume compared to NaCl. This can most probably be explained by the polysorbate-type nonionic surfactant Tween 20 being an ingredient of binding buffer. As surfactant, it increases the potential of the solution to remove entities from solid surfaces. This could possibly have reduced the amount of adherent bacteria. Furthermore, membrane integrity is significantly reduced in NaCl compared to binding buffer. This is most likely due to the low pH and low osmolality of 0.2 mM NaCl being non-physiological to the bacteria. Finally, the smaller effect of AgAu NPs on metabolic activity of early-stage biofilms in NaCl can be explained likewise as for planktonic bacteria, with less reduction possible when the metabolic activity is already low. This might be enhanced by the fact that, due to biofilm volume in NaCl being higher, the ratio of nanoparticle/bacterial cell is lower. Nevertheless, even with differences in magnitude, AgAu NPs were able to exert anti-biofilm properties in both media analyzed. 0.2 mM NaCl is the ideal medium for AgAu NP stability and therefore favorable for effectiveness²⁷. However, it might distort results by being non-physiological for bacteria. Binding buffer is closer to physiological conditions. Since application in 0.2 mM NaCl may not be feasible, binding buffer could be more relevant for possible future applications. Additionally, it would be especially relevant if target specific entities, like species-specific aptamers, were to be attached to the nanoparticles^30,36.

After analyzing early-stage biofilms, the antibacterial effect of AgAu NPs was assessed for 24 h-old, mature biofilms using similar methods. As for early-stage biofilms, an effect of AgAu NPs on metabolic activity and membrane integrity could be observed for mature biofilms, while biofilm volume was unaffected. These results demonstrate that AgAu NPs can significantly damage even mature biofilms. However, the effect on metabolic activity was considerably weaker than against early-stage biofilms. This can be explained by the increased number of bacteria and thicker biofilm matrix, which roughly doubled in both media compared to the previous experiment and increase the natural biofilm resilience. The effect on membrane integrity was also reduced, but only slightly. However, membrane integrity is still affected significantly less than metabolic activity. This again strengthens the hypothesis of silver’s mechanism of action primarily targeting metabolic pathways²¹. As for early-stage biofilms, the different media influenced the magnitude of AgAu NPs’ antibacterial effect, however, differences were less pronounced. This is most likely due to the mature biofilm being more resilient towards the unphysiological properties of 0.2 mM NaCl, while the influence of the surfactant Tween 20 remains similar.

The results presented above clearly point towards a strong impact of AgAu NPs on bacterial metabolic activity in biofilms. As it has been described that silver nanoparticles affect bacteria by releasing silver ions, which are then able to enter and damage the cells²⁴, this effect would be in line with the known molecular mechanism of silver ions²¹. In the following, this hypothesis was addressed in more detail.

The first precondition for AgAu NPs to affect the metabolic activity of bacteria in biofilms would be a sufficient diffusion through the biofilm matrix, which is known to act as a diffusion barrier^43,44. To investigate this, CLSM images of mature biofilms were sliced into 4 µm thick sections horizontally by digital image analysis and then separately analyzed for membrane integrity. The results not only showed an increase of impaired membranes in the deeper layers of the biofilm independently of the medium, but also a homogeneous increase in all sections upon treatment. This indicates that AgAu NPs were able to diffuse through the entire biofilm and could damage cell membranes – and most probably also metabolic activity – even at the bottom biofilm layer. Whether the AgAu NPs themselves are able to diffuse through the matrix, or only the silver ions they release, needs to be further investigated.

Next, the influence of AgAu NPs on the expression of some bacterial genes in comparison to silver ions was analyzed by RNA isolation and qRT-PCR. Two chosen genes are known silver targets: pfkA and ahpD encode phosphofructokinase A of glycolysis and alkylhydroperoxidase D in the oxidative stress response system, respectively²¹. The third selected gene, icaR, represses the ica operon and thus decreases biofilm formation, which would be interesting regarding future applications⁵⁰.

Treatment with AgAu NPs resulted in a slightly increased expression of pfkA and a decreased expression of ahpD and icaR to 0.04-fold and 0.2-fold, respectively. Silver ion treatment was applied in form of AgNO₃ and resulted in a 4-fold and 25-fold increased expression of pfkA and ahpD, respectively, and a slightly decreased expression of icaR. By analyses on RNA- and protein-level, Wang et al. could demonstrate that upregulation of a gene was indirectly caused by the inhibition of the encoded enzyme by silver ions²¹. For downregulation, a likewise promoting effect on the protein level can be assumed, for example by damage to relevant feedback loops. Upregulation of pfkA by AgAu NPs is in line with the results for pure silver ions and also with those from Wang et al.²¹. This points towards a damage of glycolysis also by AgAu NPs and/or its released silver ions, which would additionally fit to the reduced metabolic activity values. As glycolysis is an important virulence factor of S. aureus, its inhibition might be an important tool in treating S. aureus infections⁵¹. In contrast to the effect of pure silver ions and to the observations by Wang et al. ²¹, expression of ahpD was reduced upon AgAu NP treatment. It could thus not be concluded that AgAu NPs likewise impair the alkylhydroperoxidase D of the stress response system, but instead possibly promotes its stability by targeting feedback loops. Alternatively, the effect could be explained by the magnitude of antibacterial activity. Since AgAu NPs release a small amount of their silver into the solution as ions but AgNO₃ dissolves completely, the latter cause a stronger antibacterial effect (Supplementary Figure 1). Perhaps there are different damage thresholds at which the cells focus on specific pathways or different amounts of silver ions are required to inhibit different components of the cell. However, the exact mechanism would need to be clarified in future studies. In contrast, the biofilm inhibitor gene icaR was downregulated upon both, AgAu NP and silver ion treatment. This is in line with findings from Wang et al., who described a final downregulation of icaR at inhibitory silver concentrations⁵². This could again indicate a potential counterbalancing due to a direct or indirect promotion of the IcaR protein by silver. However, if silver indeed has the potential to impair S. aureus biofilm formation on the molecular level needs to be addressed in further studies. In this study, first insights could be achieved that the effect of AgAu NPs on S. aureus metabolic activity is based on targeting central molecular pathways like glycolysis with similarity to silver ions, which strengthens silver ions to be the major antibacterial agent of these nanoparticles.

On the way towards alternative antibacterial substances to combat the increasing number of antibiotic-resistant bacterial strains, ultrapure, surfactant-free AgAu NPs with a gold molar fraction of 0.2 synthesized by laser ablation in liquids were analyzed in this study on different stages of S. aureus biofilm formation. It could be shown that AgAu NPs exhibit antibacterial properties against planktonic bacteria but also against early-stage and even mature biofilms, with a complete diffusion of the antibacterial species (NP or silver ions) through the biofilm matrix. Furthermore, AgAu NPs primarily targeted metabolic activity and to a smaller extend membrane integrity. This is in line with the known mechanism of pure silver ions, which was further supported by initial analysis on the molecular level. On this basis, future research should be conducted analyzing the underlying mechanisms in more detail and also aiming for further modifications that allow either for a more targeted antibacterial effect or an entire biofilm eradication based on the here studied promising silver-gold-alloy nanoparticles.

Silver-Gold nanoparticle synthesis

For all experiments, surfactant free colloidal AgAu NPs consisting of 80 mol% silver and 20 mol% gold were used. They were synthesized by pulsed laser ablation in liquids, using a 1064 nm Nd-YAG laser with 10 ns pulse length, 10 kHz repetition rate and a fluence of 23.5 J/cm². For this purpose, pure solid metal targets of the respective alloy (0.5 mm thickness, 99.99 % purity, Institute for Noble Metal and Metal Chemistry, Schwäbisch-Gmünd, Germany) were fixed in a self-constructed 30 mL PTFE batch chamber⁵³. Size-quenching and electrostatic stabilization was achieved by adding a diluted electrolyte (0.2 mM NaCl) in Milli-Q water (18 M𝛺 resistance)^27,54,55. During the synthesis, the liquid was continuously stirred to minimize shielding and reirradiation effects. A galvanometric scanner system (SCANcube10, SCANLAB GmbH, Puchheim, Germany) guided the pulses to an f-theta lens (f = 100 mm) which focused the pulses in a spiral pattern on the surface of the target. The ablations were carried out for 10 min each time.

Nanoparticle characterization

Colloidal nanoparticles were characterized by UV-Vis spectroscopy, transmission electron microscopy (TEM), and X-ray-fluorescence (XRF) spectroscopy. UV-Vis spectroscopy was done using a Thermo Scientific Evolution 201 spectrometer (Thermo Fisher Scientific Inc., Waltham, MA, USA) in a wavelength range 300 – 900 nm in a quartz cuvette with a path length of 10 mm. For TEM analysis, colloidal suspensions were drop-casted on a carbon-coated copper grid and analyzed using a Zeiss EM 910 instrument (Carl Zeiss Microscopy Deutschland GmbH, Oberkochen, Germany) with an acceleration voltage of 120 kV. The bulk composition of the colloid was measured via XRF using the Bruker WD XRF S8 Tiger (Bruker, Billerica, MA, USA). The standard QuantExpress method^56,57 was used to analyze the colloid. Measurements were performed at 4 kW with a 34 mm aperture in a cuvette with a 4 µm Prolene® membrane from Chemplex Industries Inc. (Palm City, FL, USA). 9 g of the colloid sample was placed in the cuvette and measured in a 300 mbar helium atmosphere. AgAu NPs were deployed as surface concentrations based on procedures described elsewhere in more detail^30,35. In short, the total surface area was determined from known mass concentrations of the colloids in combination with surface-weighted particle size distributions obtained either from TEM or analytical disk centrifugation, assuming spherical shape for the corresponding NPs.

Bacterial strain and culture conditions

Staphylococcus aureus DSM 20231 was obtained from the German Collection of Microorganisms and Cell Cultures GmbH (DSMZ, Braunschweig, Germany) and stored at -80 °C as glycerol stocks. The bacteria were cultured overnight in tryptone soya broth (TSB, Oxoid Deutschland GmbH, Wesel, Germany) supplemented with 10 % yeast extract (Carl Roth GmbH + Co. KG, Karlsruhe, Germany) (TSBy) at 37 °C under aerobic conditions and agitated at 200 rpm.

Incubation of planktonic S. aureus with nanoparticles

After incubation overnight, the optical densities (OD₆₀₀) of the bacterial cultures were measured (BioPhotometer, Eppendorf SE, Hamburg, Germany) and adjusted to 1. Three biological replicates were used. 100 µL of bacteria suspension were mixed with 900 µL of 0.2 mM NaCl (Sigma Aldrich, St. Louis, MO, USA) or binding buffer (100 mM NaCl, 20 mM Tris, 10 mM MgCl₂, 5 mM KCl, 1 mM CaCl₂, 0.005 % Tween 20, all Carl Roth GmbH + Co. KG, pH 7.6)³⁶ containing different surface concentrations of AgAu NPs, for a final OD₆₀₀ of 0.1. The chosen surface concentrations were 0.625 cm²/mL, 1.25 cm²/mL, 2.5 cm²/mL, and 5 cm²/mL. 200 µL of each mixture were then added to a 96-well plate (Thermo Fisher Scientific Inc.) with four technical replicates for each biological replicate and incubated for 3 h at 37 °C under aerobic conditions and agitation at 450 rpm.

Incubation of S. aureus biofilms with nanoparticles

For biofilm formation, overnight cultures were diluted to an OD₆₀₀ of 0.1 in TSBy supplemented with 50 mM glucose (Carl Roth GmbH + Co. KG) and subsequently applied to either 6-well plates (for microscopic analysis; Greiner Bio-One GmbH, Frickenhausen, Germany) or 96-well plates (for analysis of metabolic activity) and incubated for 5 h and 24 h at 37 °C under aerobic conditions, respectively. Formed biofilms were washed once with 0.2 mM NaCl or binding buffer and then incubated with different concentrations of AgAu NPs in 0.2 mM NaCl or binding buffer for 18 h at 37 °C under aerobic conditions and agitation at 300 rpm.

Quantifying bacterial metabolic activity by resazurin assay

To analyze viability of S. aureus after incubation with AgAu NPs, the metabolic activity was measured using an established resazurin assay³⁹ with a slight modification. For planktonic bacteria, 30 µL of 0.01 % resazurin (Sigma Aldrich) in 0.2 mM NaCl or binding buffer mixed with 10 % TSBy were added to each well. For biofilms, wells were washed once with 0.2 mM NaCl or binding buffer and afterwards 100 µL of 0.001 % resazurin in 0.2 mM NaCl or binding buffer containing 10 % TSBy supplemented with 50 mM glucose were added. The mixtures were then incubated for 90 min at 37 °C under aerobic conditions and agitation at 450 rpm. Afterwards, fluorescence signal was measured using a plate reader (M200 PRO, Tecan Group AG, Männedorf, Switzerland) with an excitation wavelength of 530 nm and an emission wavelength of 590 nm.

Biofilm fluorescence staining, confocal laser scanning microscopy and software-based image analysis

Biofilm volume and membrane integrity were quantified by staining biofilms with the fluorescent dyes SYTO®9 and propidium iodide using the LIVE/DEAD® BacLight™ Bacterial Viability Kit (Life Technologies, Darmstadt, Germany) and acquiring images by confocal laser scanning microscopy (CLSM, Leica SP-8, Leica Microsystems, Wetzlar, Germany). The dye stock solutions were applied to biofilms in a concentration of 1:2000 in phosphate buffered saline (PBS, Sigma Aldrich) for 15 min. Following staining, biofilms were fixated by incubating them for 15 min at 4 °C in 2.5 % glutardialdehyde (Carl Roth GmbH + Co. KG) in PBS. For microscopy, biofilms were immersed in PBS and a 63x water immersion objective was used. Total magnification was 630x. Biofilms were excited using 488 nm and 552 nm lasers. Emission was detected at 500-540 nm for SYTO®9 (green), which stains all cells, and at 675-750 nm for propidium iodide (red), which only stains damaged cells and is supposed to replace SYTO®9. Consequently, cells stained by both dyes were defined as damaged cells. Image stacks were acquired in a 1024 x 1024 pixel area with a z-step size of 2 µm. Image data processing was done using the Imaris x64 8.4.1 software package (BitPlane AG, Zurich, Switzerland), where volumes of green and red channels were evaluated using the Surface function. Volume containing both dyes was afterwards subtracted from the green volume by colocalization analysis.

Furthermore, single z-planes within biofilms were evaluated for membrane integrity to analyze diffusion of NPs through biofilms. Leica Application Suite (LAS X, Leica Microsystems) was used to extract single images from the data and ImageJ 1.48v (Wayne Rasband, National Institutes of Health, Bethesda, MD, USA) was used to analyze the images. Planes were taken starting from the bottom of the biofilm and subsequently every 4 µm.

RNA isolation, cDNA synthesis and qRT-PCR

To analyze the effect of AgAu NPs on S. aureus on the transcription level, 1 mL of S. aureus overnight culture was added to 19 mL of fresh TSBy and incubated for 3 h. Afterwards, the OD₆₀₀ was measured and adjusted to 0.1 in 20 mL of binding buffer, either with or without 1.25 cm²/mL AgAu NPs. This mixture was then incubated for 3 h at 37 °C under aerobic conditions and agitation at 200 rpm. After centrifugation at 4000 g for 15 min, the resulting pellet was rinsed with PBS once and centrifugation was repeated. The pellet was diluted in RNAprotect (QIAGEN GmbH, Hilden, Germany) and incubated for 5 min at room temperature as 750 µL aliquots. Afterwards, bacteria were harvested by centrifugation at 5000 g for 10 min and stored at -20 °C until RNA isolation. This entire process was repeated with 1 µg/mL dissolved AgNO₃ instead of AgAu NPs for a comparison with silver ions.

For RNA isolation, the QIAGEN® RNeasy® Mini Kit (QIAGEN GmbH) was used as described in the manufacturer’s protocol. The isolated RNA was additionally treated with RNase-Free DNase Set (QIAGEN GmbH) to remove genomic DNA from the samples. To quantify the amount of RNA and determine its quality, samples were measured using a 2100 Bioanalyzer system (Agilent Technologies, Santa Clara, CA, USA). Afterwards, RNA was transcribed to cDNA using the QuantiTect® Reverse Transcription Kit (QIAGEN GmbH) according to the manufacturer’s protocol. For quantification of gene expression, quantitative real-time polymerase chain reaction (qRT-PCR) was performed using the iQ™ SYBR® Green Supermix (Bio-Rad Laboratories GmbH, Feldkirchen, Germany) following the manufacturer’s protocol. As potentially influenced genes, pfkA (ATP-dependent 6-phosphofructokinase), ahpD (Alkylhydroperoxidase), and icaR (Biofilm operon icaADBC HTH-type negative transcriptional regulator) were chosen and rrsA (ribosomal RNA⁵⁸) was chosen as housekeeping gene. Primers, temperatures, elongation times, and number of cycles are given in Supplementary Table 1 and Supplementary Table 2. The qRT-PCR data were analyzed using the 2^-^ΔΔ^C^T-method³⁴.

Statistical Analysis

Data presentation and statistical analysis were done using GraphPad Prism 8.4 (GraphPad Software Inc., San Diego, CA, USA). Every set of data was tested for normal distribution and consequently analyzed for statistical significance. If data were normally distributed, it was analyzed by one-way ANOVA or unpaired t tests, otherwise it was analyzed by Kruskal Wallis’ or Friedman’s test, each with a multiple comparisons test. The threshold for statistical significance for all comparisons was defined with α = 0.05.

Data availability

The datasets used and/or analyzed during the current study are available from the corresponding authors ([email protected] or [email protected]) on reasonable request.

Acknowledgements

This work was funded by the Deutsche Forschungsgesellschaft (German Research Foundation, DFG) within the project “Selectively Antibacterial Silver-Gold Alloy Nanoparticles Conjugated with Target Specific Aptamer Sequences”, project number 356685838. The authors would like to thank Wiebke Smolinksi for excellent technical assistance.

Author contributions statement

NH performed and analyzed all biological experiments, wrote the initial manuscript, and prepared figures 2-6. KDN supervised biological experiments, interpretation of data, and reviewed the manuscript. FS synthesized the nanoparticles, wrote parts of the initial manuscript, and reviewed the manuscript. JJ performed characterization of the nanoparticles, prepared figure 1, and reviewed the manuscript. AIT planned parts of the biological experiments and reviewed the manuscript. CR supervised nanoparticle synthesis and characterization, wrote parts of the initial manuscript, and reviewed the manuscript. AW supervised biological experiments, interpretation of data, and reviewed the manuscript. SB and MS conceptualized the work and supervised all experiments, interpretation and manuscript writing.

Additional Information

The authors declare no conflict of interest.

Zimmerli, W. Clinical presentation and treatment of orthopaedic implant-associated infection. J Intern Med 276, 111–119 (2014).
Romanos, G. E., Javed, F., Delgado-Ruiz, R. A. & Calvo-Guirado, J. L. Peri-implant Diseases. Dental Clinics of North America 59, 157–178 (2015).
Kapadia, B. H. et al. Periprosthetic joint infection. The Lancet 387, 386–394 (2016).
Dreyer, H. et al. Epidemiology and risk factors of peri-implantitis: A systematic review. J Periodont Res 53, 657–681 (2018).
Smeets, R. et al. Definition, etiology, prevention and treatment of peri-implantitis – a review. Head Face Med 10, 34 (2014).
Kirkfeldt, R. E. et al. Management of Cardiac Electronic Device Infections: Challenges and Outcomes. Arrhythmia & Electrophysiology Review 5, 183 (2016).
Otto-Lambertz, C., Yagdiran, A., Wallscheid, F., Eysel, P. & Jung, N. Periprosthetic Infection in Joint Replacement. Deutsches Ärzteblatt international (2017) doi:10.3238/arztebl.2017.0347.
Munita, J. M. & Arias, C. A. Mechanisms of Antibiotic Resistance. Microbiol Spectr 4, 4.2.15 (2016).
Sydnor, E. R. M. & Perl, T. M. Hospital Epidemiology and Infection Control in Acute-Care Settings. Clin Microbiol Rev 24, 141–173 (2011).
Hall-Stoodley, L., Costerton, J. W. & Stoodley, P. Bacterial biofilms: from the Natural environment to infectious diseases. Nat Rev Microbiol 2, 95–108 (2004).
Davies, D. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov 2, 114–122 (2003).
Donlan, R. M. Biofilms: Microbial Life on Surfaces. Emerg. Infect. Dis. 8, 881–890 (2002).
Stoodley, P., Sauer, K., Davies, D. G. & Costerton, J. W. Biofilms as Complex Differentiated Communities. Annu. Rev. Microbiol. 56, 187–209 (2002).
Wingender, J., Neu, T. R. & Flemming, H.-C. What are Bacterial Extracellular Polymeric Substances? in Microbial Extracellular Polymeric Substances (eds. Wingender, J., Neu, T. R. & Flemming, H.-C.) 1–19 (Springer Berlin Heidelberg, 1999). doi:10.1007/978-3-642-60147-7_1.
Archer, N. K. et al. Staphylococcus aureus biofilms: Properties, regulation, and roles in human disease. Virulence 2, 445–459 (2011).
Lee, A. S. et al. Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers 4, 18033 (2018).
Cassini, A. et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. The Lancet Infectious Diseases 19, 56–66 (2019).
European Centre for Disease Prevention and Control (ECDC). Surceillance Atlas of Infectious Diseases. https://atlas.ecdc.europa.eu/public/index.aspx.
Vila, J., Moreno-Morales, J. & Ballesté-Delpierre, C. Current landscape in the discovery of novel antibacterial agents. Clinical Microbiology and Infection 26, 596–603 (2020).
Melaiye, A. & Youngs, W. J. Silver and its application as an antimicrobial agent. Expert Opinion on Therapeutic Patents 15, 125–130 (2005).
Wang, H. et al. Multi-target mode of action of silver against Staphylococcus aureus endows it with capability to combat antibiotic resistance. Nat Commun 12, 3331 (2021).
Paladini, F. & Pollini, M. Antimicrobial Silver Nanoparticles for Wound Healing Application: Progress and Future Trends. Materials 12, 2540 (2019).
Johnston, H. J. et al. A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity. Critical Reviews in Toxicology 40, 328–346 (2010).
Tripathi, N. & Goshisht, M. K. Recent Advances and Mechanistic Insights into Antibacterial Activity, Antibiofilm Activity, and Cytotoxicity of Silver Nanoparticles. ACS Appl. Bio Mater. 5, 1391–1463 (2022).
Menéndez-Manjón, A. et al. Ligand-free gold–silver nanoparticle alloy polymer composites generated by picosecond laser ablation in liquid monomer. Appl. Phys. A 110, 343–350 (2013).
Lee, I., Han, S. W. & Kim, K. Production of Au–Ag alloy nanoparticles by laser ablation of bulk alloys. Chem. Commun. 1782–1783 (2001) doi:10.1039/b105437f.
Rehbock, C. et al. Current state of laser synthesis of metal and alloy nanoparticles as ligand-free reference materials for nano-toxicological assays. Beilstein J. Nanotechnol. 5, 1523–1541 (2014).
Grade, S. et al. Alloying colloidal silver nanoparticles with gold disproportionally controls antibacterial and toxic effects. Gold Bull 47, 83–93 (2014).
Dallaire, A.-M., Rioux, D., Rachkov, A., Patskovsky, S. & Meunier, M. Laser-Generated Au–Ag Nanoparticles For Plasmonic Nucleic Acid Sensing. J. Phys. Chem. C 116, 11370–11377 (2012).
Stein, F., Schielke, A., Barcikowski, S. & Rehbock, C. Influence of Gold/Silver Ratio in Ablative Nanoparticles on Their Interaction with Aptamers and Functionality of the Obtained Conjugates. Bioconjugate Chem. 32, 2439–2446 (2021).
Neumeister, A., Jakobi, J., Rehbock, C., Moysig, J. & Barcikowski, S. Monophasic ligand-free alloy nanoparticle synthesis determinants during pulsed laser ablation of bulk alloy and consolidated microparticles in water. Phys. Chem. Chem. Phys. 16, 23671–23678 (2014).
Prymak, O., Jakobi, J., Rehbock, C., Epple, M. & Barcikowski, S. Crystallographic characterization of laser-generated, polymer-stabilized 4 nm silver-gold alloyed nanoparticles. Materials Chemistry and Physics 207, 442–450 (2018).
Flemming, H.-C. et al. Biofilms: an emergent form of bacterial life. Nat Rev Microbiol 14, 563–575 (2016).
Livak, K. J. & Schmittgen, T. D. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method. Methods 25, 402–408 (2001).
Stein, F. et al. Disproportional surface segregation in ligand-free gold–silver alloy solid solution nanoparticles, and its implication for catalysis and biomedicine. Faraday Discuss. 242, 301–325 (2023).
Stoltenburg, R., Krafčiková, P., Víglaský, V. & Strehlitz, B. G-quadruplex aptamer targeting Protein A and its capability to detect Staphylococcus aureus demonstrated by ELONA. Sci Rep 6, 33812 (2016).
Durán, N. et al. Silver nanoparticles: A new view on mechanistic aspects on antimicrobial activity. Nanomedicine: Nanotechnology, Biology and Medicine 12, 789–799 (2016).
Pettit, R. K. et al. Microplate Alamar Blue Assay for Staphylococcus epidermidis Biofilm Susceptibility Testing. Antimicrob Agents Chemother 49, 2612–2617 (2005).
Doll, K., Jongsthaphongpun, K. L., Stumpp, N. S., Winkel, A. & Stiesch, M. Quantifying implant-associated biofilms: Comparison of microscopic, microbiologic and biochemical methods. Journal of Microbiological Methods 130, 61–68 (2016).
Salunke, G. R. et al. Rapid efficient synthesis and characterization of silver, gold, and bimetallic nanoparticles from the medicinal plant Plumbago zeylanica and their application in biofilm control. IJN 2635 (2014) doi:10.2147/IJN.S59834.
Gurunathan, S., Han, J. W., Kwon, D.-N. & Kim, J.-H. Enhanced antibacterial and anti-biofilm activities of silver nanoparticles against Gram-negative and Gram-positive bacteria. Nanoscale Res Lett 9, 373 (2014).
Bhatia, E. & Banerjee, R. Hybrid silver–gold nanoparticles suppress drug resistant polymicrobial biofilm formation and intracellular infection. J. Mater. Chem. B 8, 4890–4898 (2020).
Daddi Oubekka, S., Briandet, R., Fontaine-Aupart, M.-P. & Steenkeste, K. Correlative Time-Resolved Fluorescence Microscopy To Assess Antibiotic Diffusion-Reaction in Biofilms. Antimicrob Agents Chemother 56, 3349–3358 (2012).
Ordax, M., Marco-Noales, E., López, M. M. & Biosca, E. G. Exopolysaccharides favor the survival of Erwinia amylovora under copper stress through different strategies. Research in Microbiology 161, 549–555 (2010).
Monzón, M., Oteiza, C., Leiva, J., Lamata, M. & Amorena, B. Biofilm testing of Staphylococcus epidermidis clinical isolates: low performance of vancomycin in relation to other antibiotics. Diagnostic Microbiology and Infectious Disease 44, 319–324 (2002).
Amato, S. M. et al. The role of metabolism in bacterial persistence. Front. Microbiol. 5, (2014).
Jung, W. K. et al. Antibacterial Activity and Mechanism of Action of the Silver Ion in Staphylococcus aureus and Escherichia coli. Appl Environ Microbiol 74, 2171–2178 (2008).
Li, W.-R. et al. Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli. Appl Microbiol Biotechnol 85, 1115–1122 (2010).
Kim, S.-H. et al. Antibacterial activity of silver-nanoparticles against Staphylococcus aureus and Escherichia coli. Korean J. Microbiol. Biotechnol 39, 77–85 (2011).
Yu, D., Zhao, L., Xue, T. & Sun, B. Staphylococcus aureus autoinducer-2 quorum sensing decreases biofilm formation in an icaR-dependent manner. BMC Microbiol 12, 288 (2012).
Vitko, N. P., Spahich, N. A. & Richardson, A. R. Glycolytic Dependency of High-Level Nitric Oxide Resistance and Virulence in Staphylococcus aureus. mBio 6, e00045-15 (2015).
Wang, J. et al. Silver-nanoparticles-modified biomaterial surface resistant to staphylococcus: new insight into the antimicrobial action of silver. Sci Rep 6, 32699 (2016).
Angelov, S. D. et al. Electrophoretic deposition of ligand-free platinum nanoparticles on neural electrodes affects their impedance in vitro and in vivo with no negative effect on reactive gliosis. J Nanobiotechnol 14, 3 (2016).
Pfeiffer, C. et al. Interaction of colloidal nanoparticles with their local environment: the (ionic) nanoenvironment around nanoparticles is different from bulk and determines the physico-chemical properties of the nanoparticles. J. R. Soc. Interface. 11, 20130931 (2014).
Merk, V. et al. In Situ Non-DLVO Stabilization of Surfactant-Free, Plasmonic Gold Nanoparticles: Effect of Hofmeister’s Anions. Langmuir 30, 4213–4222 (2014).
Singh, R., Kainth, H. S., Prasher, P. & Singh, T. Trace elemental analysis of human breast cancerous blood by advanced PC-WDXRF technique. Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms 419, 44–48 (2018).
Pioneer Hill Software LLC. http://www.spectraplus.com/Downloads.htm.
Date, S. V. et al. Global Gene Expression of Methicillin-resistant Staphylococcus aureus USA300 During Human and Mouse Infection. The Journal of Infectious Diseases 209, 1542–1550 (2014).

No competing interests reported.

ManuskriptAgAuNPsagainstSaureusBiofilmSupplementaryInformation.docx

Download PDF

Journal Publication

published 10 Feb, 2024

Read the published version in Scientific Reports →

Editorial decision: Revision requested
04 Nov, 2023
Reviews received at journal
22 Oct, 2023
Reviewers agreed at journal
17 Oct, 2023
Reviews received at journal
03 Oct, 2023
Reviewers agreed at journal
21 Sep, 2023
Reviewers invited by journal
19 Sep, 2023
Editor assigned by journal
19 Sep, 2023
Editor invited by journal
19 Sep, 2023
Submission checks completed at journal
19 Sep, 2023
First submitted to journal
08 Sep, 2023

You are reading this latest preprint version

Anti-Biofilm Properties of Laser-Synthesized, Ultrapure Silver-Gold-Alloy Nanoparticles against Staphylococcus aureus

Status:

Journal Publication

Version 1

Abstract

Figures

Introduction

Results

Generation of AgAu NPs with monodisperse size distribution and molar gold fraction of 0.2

Reduced metabolic activity of planktonic S. aureus upon treatment with AgAu NPs

Different effects of AgAu NPs on S. aureus biofilm viability, volume and membrane integrity

Complete diffusion of AgAu NPs through S. aureus biofilms

AgAu NPs target expression of S. aureus metabolic genes

Discussion

Conclusion

Materials & methods

Silver-Gold nanoparticle synthesis

Nanoparticle characterization

Bacterial strain and culture conditions

Incubation of planktonic S. aureus with nanoparticles

Incubation of S. aureus biofilms with nanoparticles

Quantifying bacterial metabolic activity by resazurin assay

Biofilm fluorescence staining, confocal laser scanning microscopy and software-based image analysis

RNA isolation, cDNA synthesis and qRT-PCR

Statistical Analysis

Declarations

Data availability

Author contributions statement

Additional Information

References

Additional Declarations

Supplementary Files

Status:

Journal Publication

Version 1